Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331:109-110 (9 July), doi:10.1136/bmj.331.7508.109-b
| The first 150 words of the full text of this article appear below. |
EDITORFor more than a decade it has been an article of faith in evidence based medicine that randomised controlled trials are "best evidence" and their findings can routinely be extrapolated to clinical situations.1 In his editorial Sackett, the founder of evidence based medicine, seeks retrospectively to reassure clinicians that this practice was justifiable, but the accompanying study by Vist et al fails to tackle the question.2
Most randomised controlled trials are not hypothesis testing experiments but epidemiological comparisons of rival treatments that measure the effect size of the treatment in a sample drawn from a population.3 For the measurement to be precise, a sample needs to be sufficiently large; and to be extrapolated to the population, a sample needs to be representative (a census of all cases or a random sample).4 Problems of small samples can be overcome by megatrials, but ever larger randomised controlled trials and meta-analyses
Bruce G Charlton, reader in evolutionary psychiatry
School of Biology, University of Newcastle upon Tyne, Newcastle upon Tyne NE1 7RU bruce.charlton@ncl.ac.uk